March 7th 2022December 2nd 2021 Shorla Oncology at ASH, Atlanta, Georgia 2021 Read more at: https://www.hematology.org/meetings/annual-meeting
Our CEO on Biocentury’s Bio€quity Europe podcastMay 18th 2022Read More Our CEO on Biocentury’s Bio€quity Europe podcast
Our CCO, Nicholas Holsman speaks at the MassBio ConferenceMay 5th 2022Read More Our CCO, Nicholas Holsman speaks at the MassBio Conference
Shorla Oncology Appoints Dennis Purcell as ChairmanMarch 29th 2022Read More Shorla Oncology Appoints Dennis Purcell as Chairman
Company Name Change: Shorla Pharma is now Shorla Oncology!March 10th 2022Read More Company Name Change: Shorla Pharma is now Shorla Oncology!
Shorla Oncology at Bio CEO & Investor conference, New York 2022February 14th 2022Read More Shorla Oncology at Bio CEO & Investor conference, New York 2022
Shorla Oncology at Euronext IPO ready programme, Dublin 2022February 14th 2022Read More Shorla Oncology at Euronext IPO ready programme, Dublin 2022
3 Keys To A Successful Biotech LaunchFebruary 1st 2022Read More 3 Keys To A Successful Biotech Launch
Shorla: making women’s and children’s cancer drugs more accessibleDecember 22nd 2021Read More Shorla: making women’s and children’s cancer drugs more accessible
CEO Sharon Cunningham met with Minister Robert Troy at Enterprise Ireland’s trade visit in BostonNovember 4th 2021Read More CEO Sharon Cunningham met with Minister Robert Troy at Enterprise Ireland’s trade visit in Boston
